[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

栃谷史郎 et al., 2001 - Google Patents

The gene, occ, is preferentially expressed in the primary visual cortex in an activity-dependent manner: a pattern of gene expression strikingly related to the functional …

栃谷史郎 et al., 2001

View PDF
Document ID
3024167636911432048
Author
栃谷史郎
トチタニシロウ
Publication year

External Links

Snippet

Marker molecules to visualize specific subsets of neurons are useful for studying how the neocortex is organized to function. One approach to identify such molecular markers is to examine the differences in molecular properties among morphologically and physiologically …
Continue reading at ir.soken.ac.jp (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Schwarzer 30 years of dynorphins—new insights on their functions in neuropsychiatric diseases
Bark et al. Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development.
Wenz et al. RETRACTED: mTERF2 Regulates Oxidative Phosphorylation by Modulating mtDNA Transcription
US9475868B2 (en) Antibodies that specifically bind to DRG11-responsive (DRAGON) proteins
US5658786A (en) DNA encoding rat taurine transporter and uses thereof
Tochitani et al. The occ1 gene is preferentially expressed in the primary visual cortex in an activity‐dependent manner: a pattern of gene expression related to the cytoarchitectonic area in adult macaque neocortex
US6225115B1 (en) DNA encoding taurine and GABA transporters and uses thereof
ES2314268T3 (en) SPECIFIC PROTEIN OF BETA PANCREATIC CELLS OF THE LANGERHANS ISLANDS AND THEIR APPLICATIONS.
EP1981522B1 (en) Compositions and methods for enhancing neuronal plasticity and regeneration
Koo et al. Immunolocalization of Bex protein in the mouse brain and olfactory system
KR101649175B1 (en) Novel Samdori2 gene and using thereof
US20050014167A1 (en) Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
US20060051835A1 (en) Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease
CZ330197A3 (en) Growth modulators of central neural system neurits, pharmaceutical preparations containing thereof, cells expriming thereof, methods of their use and which lead to modulation, support and strengthening neural growth in the central neural system, improvement of memory, increase in synaptic efficiency within the central neural system and method of testing capability of the substance to modulate activity of neural adhesion molecule
栃谷史郎 et al. The gene, occ, is preferentially expressed in the primary visual cortex in an activity-dependent manner: a pattern of gene expression strikingly related to the functional area in macaque neocortex
Montpied et al. Alteration in levels of expression of brain calbindin D‐28k and calretinin mRNA in genetically epilepsy‐prone rats
George et al. Collybistin SH3‐protein isoforms are expressed in the rat brain promoting gephyrin and GABA‐A receptor clustering at GABAergic synapses
栃谷史郎 et al. The gene, occ, is preferentially expressed in the primary visual cortex in an activity-dependent manner: a pattern of gene expression strikingly related to the functional area in macaque neocortex
Seroogy et al. Transient expression of somatostatin messenger RNA and peptide in the hypoglossal nucleus of the neonatal rat
DE60024862T2 (en) "INSULIN-DEPENDENT SEQUENCE DNA BINDING PROTEIN-1" (IRSDBP-1), A GENERIC ENCODER AND ITS USES
CA2518761A1 (en) Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects
Ayoubi Regulation of proopiomelanocortin and 7B2 gene expression in the pituitary of Xenopus laevis
van't Padje Zebrafish as a model to study human disease: Functional studies of the FXR proteins
Bassi A multidisciplinary approach to characterize the role of prokineticin receptor 2 (PROKR2) in Congenital Hypogonadotropic Hypogonadism (CHH)
van‘t Padje Zebrafish as a Model to study Human Disease